CRISPR/Cas13a incorporated into microfluidic technology for nucleic acid amplification‐free miRNA diagnostics
Although CRISPR technology is well-known for its ability for gene knock-out and therapeutic applications, it has been recently evolved as a powerful technique for diagnostics purposes. The strength of CRISPR diagnostics methods along with the superiority of microfluidics in manufacturing point-of-care (POC) diagnostics chips creates...